Tarloxotinib
NSCLC, Stage IV
Rain Oncology IncPhase 2
—
Rating in progress
Tarloxotinib in NSCLC, Stage IV is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant